Skip to main content
Erschienen in: BMC Pulmonary Medicine 1/2019

Open Access 01.12.2019 | Case report

The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax

verfasst von: Wojciech Jacheć, Andrzej Tomasik, Marcin Kurzyna, Radosław Pietura, Adam Torbicki, Jan Głowacki, Ewa Nowalany-Kozielska, Celina Wojciechowska

Erschienen in: BMC Pulmonary Medicine | Ausgabe 1/2019

Abstract

Background

Systemic artery to pulmonary artery fistulas (SA-PAFs), are extremely rare in people without congenital heart disease. In this group of patients pulmonary arterial hypertension was reported in the single case. Then, we describe a case of multiple SA-PAFs, which were the cause of severe nonreversible arterial pulmonary hypertension in a patient who had a right-sided pneumothorax 35 years earlier.

Case presentation

52-year-old male Caucasian patient with echocardiographically confirmed pulmonary hypertension (PH) was admitted to cardiology department due to exertional dyspnea and signs of right ventricle failure. Routine screening for causes of secondary PH was negative. Right heart catheterization (RHC) confirmed a high degree arterial PH [mean pulmonary artery pressure (mPAP); 50,6 mmHg, pulmonary wedge pressure (PWP); 11,3 mmHg, pulmonary vascular resistance (PVR); 11,9 Wood’s units (WU)] irreversible in the test with inhaled nitric oxide. Oxygen saturation (SaO2) of blood samples obtained during the first RHC ranged from 69.3 to 73.2%. Idiopathic pulmonary arterial hypertension was diagnosed. Treatment with inhaled iloprost and sildenafil was initiated.
Control RHC, performed 5 months later showed values of mPAP (59,7 mmHg) and PVR (13,4 WU) higher in comparison to the initial measurement, SaO2 of blood obtained during RHC from upper lobe artery of the right lung was elevated and amounted 89.7%.
Then, pulmonary arteriography was performed. Lack of contrast in the right upper lobe artery with the evidence of retrograde blood flow visible as a negative contrast in the right pulmonary artery was found. Afterwards, right subclavian artery arteriography detected a huge vascular malformation communicating with right upper lobe artery. Following computed tomography angiogram (angio-CT) additionally revealed the enlargement of bronchial arteries originated fistulas to pulmonary artery of right upper lobe.
In spite of intensive pharmacological treatment, including the therapy of pulmonary hypertension and percutaneous embolisation of the fistulas, the patient’s condition continued to deteriorate further. He died three months after embolisation due to severe heart failure complicated by pneumonia.

Conclusion

Non-congenital SA-PAFs are extremely rare, however, they should be excluded in patients with pulmonary arterial hypertension and history of inflammatory or infectious disease of the lung and pleura, pneumothorax, cancer or Takayashu’s disease and after chest trauma.
Abkürzungen
ABPd
Diastolic arterial blood pressure
ABPs
Systolic arterial blood pressure
Angio-CT
Computed tomography angiography
CO
Cardiac output
HIV
Human immunodeficiency virus
HRCT
High-resolution computed tomography
INR
International normalized ratio
mABP
Mean arterial blood pressure
mg
Milligram
mPAP
Mean pulmonary artery pressure
NO
Nitric oxide
NT-proBNP
N-terminal pro-brain natriuretic peptide
O2
Oxygen
PAPd
Diastolic pulmonary artery pressure
PAPs
Systolic pulmonary artery pressure
PH
Pulmonary hypertension
ppm
Parts per million
PvO2
Venous blood oxygen saturation
PVRI
Pulmonary vascular resistance index
PWP
Pulmonary artery wedge pressure
RAP
Right atrium pressure
RHC
Right heart catheterization
RVSP
Right ventricle systolic pressure
SaO2
Systemic blood oxygenation
SA-PAFs
Systemic artery to pulmonary artery fistulas
SVRI
Systemic vascular resistance index
TAPSE
Tricuspid annular plane systolic excursion
TEE
Transesophageal echocardiography
TTE
Transthoracic echocardiography
WHO
World health organization

Background

Systemic artery to pulmonary artery fistulas (SA-PAFs) are known to develop in patients with congenital heart diseases, which are combined with right ventricular outflow or pulmonary artery obstruction and in many cases it may be the only blood supply to pulmonary circulation [1].
SA-PAFs are extremely rare in people with normal pulmonary circulation. They can be congenital and non-congenital. Non-congenital fistulas can develop in patients with inflammatory or infectious disease of the lung and pleura, cancer, Takayasu’s disease, or after trauma [24]. Congenital SA-PAFs can be detected in patients without any of the above-mentioned risk factors [5].
SA-PAF can be single or multiple and connect pulmonary vascular bed with left internal mammary artery, left subclavian artery, pericardiacophrenic branch of left inferior phrenic artery, left bronchial artery, gastric arteries or others [5, 6]. SA-PAFs are usually asymptomatic. Some patients complained about dyspnea, hemoptysis or symptoms of congestive heart failure [711]. The natural outcome of SA-PAFs is not well-known yet. SA-PAFs may be managed by embolisation, resection, or observation [1].
Only in two reported cases of congenital SA-PAFs mild elevated systolic pulmonary artery pressure (to 37 mmHg) was detected [5] and severe pulmonary arterial hypertension was reported in one case of congenital SA-PAFs [12].
We describe a case of non-congenital multiple SA-PAFs which were the cause of severe precapillary pulmonary hypertension in a patient who had right-sided pneumothorax thirty years earlier.

Case presentation

A 52-year-old male patient with initial diagnosis of pulmonary arterial was admitted to the Department of Cardiology for medical assessment and decision on further treatment. The patient had a history of right-sided spontaneous pneumothorax, treated with thoracentesis and vacuum drainage 35 years earlier. The patient felt increasing dyspnea on exertion. He also complained about signs of right ventricle failure and cyanosis. Four years earlier the patient was hospitalized three times for paroxysmal atrial fibrillation that was converted to sinus rhythm by electric cardioversion besides electrocardiographic examination was normal.
In the same year coronary angiography indicated normal coronary arteries. Echocardiography revealed mild pulmonary hypertension with calculated right ventricle systolic pressure of 36 mmHg without right ventricle dilation.
In the following years, progressive heart failure with increasing pulmonary artery pressure in echocardiography has been observed. Angio-CT was performed on two occasions and chronic thromboembolic pulmonary hypertension was excluded each time. High-resolution computed tomography has excluded interstitial pulmonary pathology. Spirometry was normal. Screening for autoimmune diseases and HIV infection was negative (Table 1).
Table 1
Timeline – history, course of the disease, diagnosis and treatment
1976
right-hand pneumothorax
2007
Hospitalized three times for atrial fibrillation and heart failure echocardiography, cardioversion, coronarography were performed. Every time discharged from the departments with diagnosis: Atrial fibrillation, Heart failure, NYHA class II.
2010–2011
Increasing growing shortness of breath and symptoms of heart failure. Patient was hospitalized 3 times. Indirect features of pulmonary hypertension in echocardiography were detected. Three times chest-CT examination was performed; pulmonary embolism or chronic thromboembolic pulmonary arterial hypertension (2 x angio-CT) or pulmonary fibrosis (high resolution computer tomography) was excluded.
Diagnosis of pulmonary hypertension was established, WHO class III.
DEC-2011
Admission to cardiology clinic – echocardiography (TTE, TEE), 6-min walking test, NT-proBNP, right heart catheterisation, pulmonary vasoreactivity test.
Diagnosis of irreversible arterial pulmonary hypertension was established.
Treatment with the illoprost and sildenafil has started
JAN-2012
control visit – improvement in WHO class, decrease of NT-proBNP concentration and increase of 6-min test distance
MAY-2012
Control RHC. SaO2 of blood samples obtained during RHC from upper lobe artery of the right lung amounted 87%.
Angiographic diagnostic of pulmonary arteries revealed PAH fistulas between subclavian and upper lobe of right lung arteries
JUN 2012
angio-CT of systemic arteries revealed additional presence of bronchial artery fistulas to upper lobe of right lung arteries
III-2013
Embolisation of fistulas
VI-2013
Death as a result of worsening of heart failure combined with pneumonia.
At admission to our clinic functional class of patient was assessed as WHO III, In physical examination the second heart sound (S2) was accentuated with widened split S2. Moreover, heart auscultation indicated holosystolic murmur of tricuspid regurgitation. The auscultation of the chest did not show a vascular murmur. Peripheral and central cyanosis was marked. Hepatomegaly, peripheral edema and varicose veins bilaterally were examined.
SaO2 obtained by pulse oximetry method was reduced to 88%. Electrocardiography revealed atrial fibrillation, right axis deviation and negative T wave in precordial leads v1-v3. Additional tests were as follows: NT-proBNP concentration – 3383 pg/ml, six-minute walking test distance - 373 m with 7/10 points in Borg dyspnea score.
Echocardiography showed features of severe pulmonary hypertension: right ventricle enlargement to 44 mm (four chamber view), with depressed function of right ventricle TAPSE 9 mm, right atrium area enlargement to 40 cm2, severe tricuspid valve regurgitation (++++), increased calculated RVSP to 112 mmHg, shortened pulmonary artery acceleration time to 60 ms and mild pericardial effusion. There was no interventricular septum defect. Trans-esophageal echocardiography did not show a defect in the atrial septum too, which was confirmed later by angio-CT (Fig. 1).
SaO2 of blood obtained from radial artery was reduced to 87,8%. Right heart catheterization was performed. SaO2 of blood samples obtained during RHC from vena cava superior, vena cava inferior, right atrium, pulmonary trunk, middle lobe artery of the right lung and left pulmonary artery amounted respectively: 64,8%; 77,4%; 73,2%; 70,2%, 69,3%; 71,2% and did not indicate the presence of a left-to-right shunt.
Hemodynamic measurements showed severe precapillary pulmonary hypertension, irreversible in vasoreactivity testing with inhaled nitric oxide (80 ppm) and a combination of oral sildenafil (50 mg) and inhaled nitric oxide (80 ppm) [13] (Table 2).
Table 2
Results of pulmonary arterial hypertension reversibility test
 
PAPs/PAPd (mPAP)
[mm Hg]
ABPs/ABPd (mABP)
[mm Hg]
PWP
[mm Hg]
PVR
[WU]
SVR
[WU]
RA
[mm Hg]
CI
[l/min./m2]
SaO2
[%]
Baseline
69,8/41,0 (50,6)
104,0/80,0 (88,3)
12,3
11,9
24,4
10,0
1,5
87,8
NO/O2 (80 ppm)
63,0/35,6 (44,7)
101,0/74,0 (83)
12,0
9,1
20,8
8,0
1,7
99,0
Sildenafil (50 mg)
68,0/37,6 (47,7)
99,5/70,0 (79,8)
12,0
8,1
16,3
8,0
2,0
84,0
NO/O2 (80 ppm)
62,0/34,4 (43,6)
98,0/72,0 (80,3)
12,5
6,9
16,2
8,0
2,1
95,2
Control RHC
75,4/51,8 (59,7)
104,0/78,0 (86,7)
13,5
13,4
21,7
12,0
1,6
90,1
PAPs systolic pulmonary artery pressure, PAPd diastolic pulmonary artery pressure, mPAP mean pulmonary artery pressure, ABPs systolic arterial blood pressure, ABPd diastolic arterial blood pressure, mABP mean arterial blood pressure, PWP pulmonary wedge pressure, PVR pulmonary vascular resistance, SVR systemic vascular resistance, RAP right atrium pressure, CI cardiac index, SaO2 systemic blood oxygenation, NO nitric oxide, O2 oxygen, ppm parts per million, RHC right heart catheterization
Based on the whole clinical data and the results of RHC, a diagnosis of idiopathic irreversible pulmonary hypertension was established.
Treatment with inhaled iloprost (Ventavis) 6 × 5 μg and sildenafil (Revatio) orally 3 × 20 mg was initiated. Moreover, digoxin (0,1 mg daily), warfarin (INR range: 2–3), furosemide (40 mg orally daily) and spironolactone (100 mg daily) were administered.
Noninvasive follow up was performed one month later – the patient reported improved physical capacity, class II WHO, NT-proBNP concentration: 1014 pg/ml. Six-minute walking test distance - 471 m.
Invasive assessment was done five months later. RHC showed higher than in initial measurements values of PAP [75,4/51,8 (59,7) mm Hg] and PVR (13,4 WU) (Table 2 – control RHC).
Oxygen saturation of blood samples obtained during RHC from upper lobe artery of the right lung was elevated and amounted 89.7%.
In the pulmonary angiography reduction of peripheral vascular drawing typical of pulmonary arterial hypertension and the lack of contrast of the right upper lobe artery were detected. Additionally the evidence of retrograde blood flow visible as a negative contrast in right pulmonary artery was found (Fig. 2 a-d). Afterwards, right subclavian artery arteriography was performed and a huge vascular malformation communicating with right upper lobe artery (Fig. 2e-k) was detected.
Angio-CT of systemic arteries confirmed presence of previously described fistulas and revealed additional presence of bronchial artery fistulas to upper lobe of right lung arteries (Fig. 3).
Selective embolisation of fistulas was performed (50% mixture of Lipiodol and monomeric n-butyl-2-cyanoacrylate glue). Embolisation did not bring any clinical change in the patient’s condition.

Discussion and conclusions

A case of 52-year-old male patient with high-grade pulmonary arterial hypertension leading to severe right ventricle failure that was irreversible in vasoreactivity testing with inhaled nitric oxide and sildenafil was reported. Patient had a right-sided pneumothorax 35 years earlier.
Multiple artery-to-artery fistulas between systemic and pulmonary circulation, existing despite normal morphologic development of pulmonary circulation were the cause leading to severe pulmonary hypertension.
During the last four years of his life, the patient presenting with cyanosis and echocardiographic evidence of pulmonary hypertension and had normal spirometry results, HRCT and angio-CT of pulmonary arteries.
Mild to moderate hypoxemia is common in arterial pulmonary hypertension patients [14, 15].
It may be possibly related to ventilation/perfusion mismatch [16], low diffusion capacity, low mixed venous PvO2 [16, 17], and sometimes existing right-to-left shunting, which is classically considered to arise from the reopening of patent foramen ovale [14, 18]. In this case normal chest radiographs, HRCT of the chest, and lack of pulmonary edema during vasodilatatory therapy excluded pulmonary veno-occlusive disease as the cause of hypoxemia [19].
We believe that in this case the probable cause of pulmonary hypertension are multiple systemic to pulmonary artery fistulas which initially cause left-to-right shunt, induce an increase in pulmonary vascular resistance which leads to an increase in pulmonary vascular resistance which eventually results in reversal of the direction of the shunt. It was responsible for the proper perfusion of the upper lobe of right lung during first two angio-CT.
In contrast, in the first RHC the ratio of mean pulmonary to systemic pressure was about 5/8, which clearly indicates the left-to-right direction of the shunt. This may be related to worsening function of right ventricle.
At the stage of the first RHC, we had no premises to extend the diagnosis towards systemic-pulmonary shunt. Moreover, unfortunately, the blood sample for the SaO2 was taken from the middle lobe artery of the right lung. After establishing the diagnosis of idiopathic pulmonary arterial hypertension, we included PAH treatment in accordance with the ESC standards. Control RHC has become a contribution to the diagnosis of multiple system-pulmonary fistulas. Only then did the patient inform us about a right-sided pneumothorax 35 years earlier.
The course of changes in pulmonary hemodynamics can be compared to changes in congenital heart defects leading to the development of the Eisenmenger syndrome but due to the observed clinical improvement, we did not decide to replace iloprost and sildenafil for the recommended endothelin-receptor antagonist [20]. Furthermore, co-occurrence of idiopathic pulmonary arterial hypertension and systemic pulmonary fistulas can’t be clearly excluded.
Finally after many discussions within the heart team, selective embolisation of fistulas was performed. Unfortunately, despite effective embolization, changes in pulmonary circulation were so advanced that removal of the cause of pulmonary hypertension did not improve the patient’s condition. In addition, closure of the fistulas blocked the “potentially” beneficial effect of right ventricular decompression in the event of a re-growth of pulmonary artery pressure to super systemic values.
In spite of intensive pharmacological treatment, including the therapy of pulmonary hypertension the patient’s condition deteriorated further. He died three months later due to severe heart failure complicated by pneumonia.
Ji-Feng Li et al. described a similar case of multiple fistulas between systemic and pulmonary arteries of right lung, which were of congenital origin. They resulted in moderate pulmonary hypertension with mean PAP value = 37 mmHg. The right ventricle function was not seriously depressed; TAPSE = 18,5 mm. Embolisation of the largest fistula resulted in a gradual drop of mPAP in six-month follow-up despite the lack of PDE5-I, ARB or prostanoids in concomitant therapy [12].

Take home message

Non congenital SA-PAFs are extremely rare, but still the diagnosis should be considered when a shunt is suspected during the diagnostic work up of pulmonary arterial hypertension, especially in patients with risk factors.

Acknowledgements

Not applicable.

Funding

The design of the case report, analysis, and interpretation of data and writing of the manuscript had no funding. If the case report is accepted for publication, the Medical University of Silesia will cover the related costs.

Availability of data and materials

All data presented come from the patient’s medical records and after their disclosure individual privacy of patient could be compromised.
All data generated or analyzed during this study are included in this published article.

Authors’ information

“WJ” – cardiologist, pulmonary hypertension specialist, deputy head of the 2nd Department of Cardiology and head of cardiac cath-lab of the 2nd Department of Cardiology of School of Medicine with Dentistry Division in Zabrze, Medical University of Silesia, 10 Ci-Sklodowska str., 41–808 Zabrze, Poland.
“AT” – cardiologist, pulmonary hypertension specialist, deputy head of cardiac cath-lab of the 2nd Department of Cardiology of School of Medicine with Dentistry Division in Zabrze, Medical University of Silesia, 10 Ci-Sklodowska str., 41–808 Zabrze, Poland.
“MK” – cardiologist, pulmonary circulation and hypertension specialist, deputy head of the Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock, 14/18 Borowa str, 05–400 Otwock, Poland. Polish Society of Cardiology expert.
“RP” – interventional radiologist, head of Department of Interventional Radiology, Department of Radiography Medical, University of Lublin, Staszica 11 str., 20–081, 20–954 Lublin, Poland.
“JG” – radiologist, lecturer of Department of Radiology and Nuclear Medicine, School of Medicine with Dentistry Division in Zabrze, Medical University of Silesia, 13–15 3-go Maja str., 41–800 Zabrze, Poland.
“ATor” – cardiologist, pulmonary circulation and hypertension specialist, head of the Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock, 14/18 Borowa str, 05–400 Otwock, Poland. European Society of Cardiology expert.
“ENK” – cardiologist, head of the 2nd Department of Cardiology of School of Medicine with Dentistry Division in Zabrze, Medical University of Silesia, 10 Ci-Sklodowska str., 41–808 Zabrze, Poland.
“CW” – cardiologist, pulmonary hypertension specialist, head of echocardiography laboratory of the 2nd Department of Cardiology of School of Medicine with Dentistry Division in Zabrze, Medical University of Silesia, 10 Ci-Sklodowska str., 41–808 Zabrze, Poland.
Presented case report was reviewed by the Bioethics Committee of the Medical University of Silesia, reference number; KNW/0022/KB/7/8.
Manuscript does not contain any individual person’s data in any form. During life, the patient gave consent for a case report publication. Because the patient died, written consent for the use of medical records was obtained from the wife of the patient.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Maeda E, Akahane M, Kato N, Hayashi N, Koga H, Yamada H, Kato H, Ohtomo K. Assessment of major aortopulmonary collateral arteries with multidetector-row computed tomography. Radiat Med. 2006;24(5):378–83.CrossRef Maeda E, Akahane M, Kato N, Hayashi N, Koga H, Yamada H, Kato H, Ohtomo K. Assessment of major aortopulmonary collateral arteries with multidetector-row computed tomography. Radiat Med. 2006;24(5):378–83.CrossRef
2.
Zurück zum Zitat Hearne SF, Burbank MK. Internal mammary artery to-pulmonary artery fistulas. Circulation. 1980;62:1131–5.CrossRef Hearne SF, Burbank MK. Internal mammary artery to-pulmonary artery fistulas. Circulation. 1980;62:1131–5.CrossRef
3.
Zurück zum Zitat Yan Y, Tweddale BA, Trerotola SO. Internal mammary artery–to–pulmonary artery and vein fistula acquired after video-assisted thoracoscopic surgery and Pleurodesis. J of Vasc Intervnet Radiol. 2013;24(11):1759–61.CrossRef Yan Y, Tweddale BA, Trerotola SO. Internal mammary artery–to–pulmonary artery and vein fistula acquired after video-assisted thoracoscopic surgery and Pleurodesis. J of Vasc Intervnet Radiol. 2013;24(11):1759–61.CrossRef
4.
Zurück zum Zitat Rieh G, Chaffanjon P, Frey G, Sessa C, Brichon P-Y. Postoperative systemic artery to pulmonary vessel fistula: analysis of three cases. Ann Thorac Surg. 2003;76:1873–7.CrossRef Rieh G, Chaffanjon P, Frey G, Sessa C, Brichon P-Y. Postoperative systemic artery to pulmonary vessel fistula: analysis of three cases. Ann Thorac Surg. 2003;76:1873–7.CrossRef
5.
Zurück zum Zitat Itano H, Lee S, Kulick DM, Iannettoni MD, Williams DM, Mark B. Orringer nontraumatic Chest Wall systemic-to-pulmonary artery fistula. Ann Thorac Surg. 2005;79:29–31.CrossRef Itano H, Lee S, Kulick DM, Iannettoni MD, Williams DM, Mark B. Orringer nontraumatic Chest Wall systemic-to-pulmonary artery fistula. Ann Thorac Surg. 2005;79:29–31.CrossRef
6.
Zurück zum Zitat Lee J-K, Park J-H, Kim J, Kim SJ, Lee A-R, Lee CH. Young-ho so mbolization of multiple systemic artery to pulmonary artery fistula with recurrent hemoptysis. Tuberc Respir Dis. 2013;75:120–4.CrossRef Lee J-K, Park J-H, Kim J, Kim SJ, Lee A-R, Lee CH. Young-ho so mbolization of multiple systemic artery to pulmonary artery fistula with recurrent hemoptysis. Tuberc Respir Dis. 2013;75:120–4.CrossRef
7.
Zurück zum Zitat Voll A, Marstrander F, Wexels P. Systemic-pulmonary shunt. Dis Chest. 1966;45:396–401.CrossRef Voll A, Marstrander F, Wexels P. Systemic-pulmonary shunt. Dis Chest. 1966;45:396–401.CrossRef
8.
Zurück zum Zitat Tadavarthy SM, Klugman J, Castaneda-Zuniga WR, et al. Systemic-to-pulmonary collaterals in pathological states. Radiology. 1982;144:55–9.CrossRef Tadavarthy SM, Klugman J, Castaneda-Zuniga WR, et al. Systemic-to-pulmonary collaterals in pathological states. Radiology. 1982;144:55–9.CrossRef
9.
Zurück zum Zitat Gallet B, Bayet G, Saudemont JP, et al. Fistule syste’mopulmonaire acquise apre` s pleurectomie responsable d’un souffle thoracique continu. Cardiol Angeiol. 1988;37:305–8. Gallet B, Bayet G, Saudemont JP, et al. Fistule syste’mopulmonaire acquise apre` s pleurectomie responsable d’un souffle thoracique continu. Cardiol Angeiol. 1988;37:305–8.
10.
Zurück zum Zitat Saito T, Matsuda M, Yamaguchi T, et al. A case of a traumatic systemic-pulmonary arteriovenous fistula. Jpn Heart J. 1975;16:196–203.CrossRef Saito T, Matsuda M, Yamaguchi T, et al. A case of a traumatic systemic-pulmonary arteriovenous fistula. Jpn Heart J. 1975;16:196–203.CrossRef
11.
Zurück zum Zitat VanDerPloeg DG, BS WRS, Krohmer SJ, O’Connor WN, Martin JT. Congenital bronchial artery to pulmonary artery fistula presenting as hemoptysis. Ann Thorac Surg. 2015;99:19–20.CrossRef VanDerPloeg DG, BS WRS, Krohmer SJ, O’Connor WN, Martin JT. Congenital bronchial artery to pulmonary artery fistula presenting as hemoptysis. Ann Thorac Surg. 2015;99:19–20.CrossRef
12.
Zurück zum Zitat Li J-F, Zhai Z-G, Kuang T-G, Liu M, Ma Z-H, Li Y-D, Yang Y-H. A case of pulmonary hypertension due to fistulas between multiple systemic arteries and the right pulmonary artery in an adult discovered for occulted Dyspnoea. Heart, Lung and Circulation. 2017;26:e54–8.CrossRef Li J-F, Zhai Z-G, Kuang T-G, Liu M, Ma Z-H, Li Y-D, Yang Y-H. A case of pulmonary hypertension due to fistulas between multiple systemic arteries and the right pulmonary artery in an adult discovered for occulted Dyspnoea. Heart, Lung and Circulation. 2017;26:e54–8.CrossRef
13.
Zurück zum Zitat Jan Wodniecki, Wojciech Jacheć, Lech Poloński, Andrzej R. Tomasik, Celina Wojciechowska, Ala Foremny. Sildenafil obniża ciśnienie i opory płucne oraz zwiększa wrażliwość tętnic płucnych na tlenek azotu w pierwotnym nadciśnieniu płucnym. Przegląd Lekarski 2005 T.62 nr 2 s. 135–138. Jan Wodniecki, Wojciech Jacheć, Lech Poloński, Andrzej R. Tomasik, Celina Wojciechowska, Ala Foremny. Sildenafil obniża ciśnienie i opory płucne oraz zwiększa wrażliwość tętnic płucnych na tlenek azotu w pierwotnym nadciśnieniu płucnym. Przegląd Lekarski 2005 T.62 nr 2 s. 135–138.
14.
Zurück zum Zitat Rich S, Dantzker D, Ayres S, Bergofsky E, Brundage B, Detre K, Fishman A, Goldring R, Groves B, Koerner S, et al. Primary pulmonary hypertension: a national prospective study. Ann Int Med. 1987;107:216–23.CrossRef Rich S, Dantzker D, Ayres S, Bergofsky E, Brundage B, Detre K, Fishman A, Goldring R, Groves B, Koerner S, et al. Primary pulmonary hypertension: a national prospective study. Ann Int Med. 1987;107:216–23.CrossRef
15.
Zurück zum Zitat Hoeper MM, Pletz MW, Golpon H, Welte T. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2007;29:944–50.CrossRef Hoeper MM, Pletz MW, Golpon H, Welte T. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2007;29:944–50.CrossRef
16.
Zurück zum Zitat Melot C, Naeije R, Mols P, Vandenbossche JL, Denolin H. Effects of nifedipine on ventilation/perfusion matching in primary pulmonary hypertension. Chest. 1983;83:203–7.CrossRef Melot C, Naeije R, Mols P, Vandenbossche JL, Denolin H. Effects of nifedipine on ventilation/perfusion matching in primary pulmonary hypertension. Chest. 1983;83:203–7.CrossRef
17.
Zurück zum Zitat Dantzker DR, Bower JS. Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease. J Clin Invest. 1979;64:1050–5.CrossRef Dantzker DR, Bower JS. Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease. J Clin Invest. 1979;64:1050–5.CrossRef
18.
Zurück zum Zitat Chen WJ, Chen JJ, Lin SC, Hwang JJ, Lien WP. Detection of cardiovascular shunts by transesophageal echocardiography in patients with pulmonary hypertension of unexplained cause. Chest. 1995;107:8–13.CrossRef Chen WJ, Chen JJ, Lin SC, Hwang JJ, Lien WP. Detection of cardiovascular shunts by transesophageal echocardiography in patients with pulmonary hypertension of unexplained cause. Chest. 1995;107:8–13.CrossRef
19.
Zurück zum Zitat Montani D, Price LC, Dorfmuller P, Achouh L, Jaïs X, Yaïci A, Sitbon O, Musset D, Simonneau G, Humbert M. Pulmonary veno-occlusive disease. Eur Respir J. 2009;33:189–200.CrossRef Montani D, Price LC, Dorfmuller P, Achouh L, Jaïs X, Yaïci A, Sitbon O, Musset D, Simonneau G, Humbert M. Pulmonary veno-occlusive disease. Eur Respir J. 2009;33:189–200.CrossRef
20.
Zurück zum Zitat Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery J-L, Barbera JA, Beghetti M, Corris P, Gaine S, Simon Gibbs J, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Rubin APL, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by: International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493–537.CrossRef Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery J-L, Barbera JA, Beghetti M, Corris P, Gaine S, Simon Gibbs J, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Rubin APL, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by: International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493–537.CrossRef
Metadaten
Titel
The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax
verfasst von
Wojciech Jacheć
Andrzej Tomasik
Marcin Kurzyna
Radosław Pietura
Adam Torbicki
Jan Głowacki
Ewa Nowalany-Kozielska
Celina Wojciechowska
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Pulmonary Medicine / Ausgabe 1/2019
Elektronische ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-019-0832-8

Weitere Artikel der Ausgabe 1/2019

BMC Pulmonary Medicine 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.